Market cap
₹15 Cr
Revenue (TTM)
₹339 Cr
P/E Ratio
7.2
P/B Ratio
0.3
Div. Yield
0 %
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
15 | 16,009 | 14,664 | 6,436 | 5,182 |
Revenue (₹ Cr) |
339 | 3,915 | 4,537 | 2,966 | 1,307 |
Net Profit (₹ Cr) |
2.03 | 753.50 | 188.20 | 284.04 | 250.86 |
Net Margin (%) |
0.60 | 18.85 | 4.14 | 9.37 | 18.79 |
RoE (%) |
3.93 | 25.89 | 3.99 | 18.77 | 30.36 |
Price to Earnings |
7.19 | 21.39 | 77.92 | 22.66 | 20.66 |
Price-To-Book |
0.32 | 5.75 | 2.47 | 3.94 | 5.77 |
Income Statement (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Operating Revenue
|
339.18 | 3,914.63 | 4,537.10 | 2,966.48 | 1,307.15 |
|
Total Income
|
340.02 | 3,996.65 | 4,545.90 | 3,032.25 | 1,335.24 |
|
Total Expenditure
|
331.99 | 2,939.02 | 3,942.90 | 2,576.09 | 1,008.83 |
|
EBITDA
|
7.18 | 975.61 | 594.20 | 390.39 | 298.32 |
|
Depreciation
|
1.03 | 175.60 | 193.00 | 62.67 | 16.76 |
|
EBIT
|
6.16 | 800.01 | 401.20 | 327.72 | 281.55 |
|
Interest
|
4.17 | 14.31 | 121.90 | 4.85 | 1.46 |
|
Other Income
|
0.84 | 82.02 | 8.80 | 65.77 | 28.09 |
|
Exceptional Items
|
-0.17 | -10.15 | -40.80 | 0.00 | 0.00 |
|
Profit before Tax
|
2.66 | 857.57 | 247.30 | 388.64 | 308.18 |
|
Provision for Tax
|
0.64 | 104.07 | 59.10 | 104.60 | 57.32 |
|
Profit after Tax
|
2.03 | 753.50 | 188.20 | 284.04 | 250.86 |
Liabilities (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
55.02 | 2,923.98 | 5,826.00 | 1,588.61 | 897.65 |
|
Minority Interest
|
0.00 | -1.58 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
1.76 | 75.76 | 3,753.30 | 107.26 | 9.68 |
|
Current Liabilities
|
91.10 | 838.24 | 728.50 | 556.49 | 161.66 |
|
Total Liabilities
|
147.88 | 3,830.51 | 10,189.90 | 2,911.23 | 945.13 |
Assets (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
13.62 | 1,839.04 | 8,738.00 | 470.32 | 311.24 |
|
Current Assets
|
133.50 | 1,934.86 | 1,366.70 | 1,493.03 | 737.86 |
|
Total Assets
|
147.88 | 3,830.51 | 10,189.90 | 2,911.23 | 945.13 |
|
Total Debt*
|
41.70 | 122.38 | 3,186.40 | 0.00 | 0.00 |
|
Net Current Assets
|
42.40 | 1,096.62 | 638.20 | 936.54 | 576.21 |
|
Contingent Liabilities
|
0.19 | 10.99 | 450.40 | 9.61 | 9.94 |
Cashflow (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
20.71 | 800.53 | 226.40 | 412.13 | 196.92 |
|
Cash Flow from Investing Activities
|
-1.35 | -181.14 | -2,909.90 | -276.95 | -14.45 |
|
Cash from Financing Activities
|
-19.36 | -554.48 | 2,698.40 | -159.77 | -196.49 |
|
Net Cash Inflow / Outflow
|
0.00 | 64.91 | 14.90 | -24.59 | -14.02 |
Ratios
Profitability Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
ROCE (%)
|
7.38 | 29.54 | 4.42 | 30.71 | 31.00 |
|
ROE (%)
|
3.93 | 25.89 | 3.99 | 18.77 | 30.36 |
|
ROA (%)
|
1.39 | 20.45 | 2.25 | 13.28 | 26.22 |
|
EBIT Margin (%)
|
1.81 | 20.44 | 8.84 | 11.05 | 21.54 |
|
Net Margin (%)
|
0.60 | 18.85 | 4.14 | 9.37 | 18.79 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
20.24 | 2.82 | 66.27 | 3.94 | 27.71 |
|
EBIT Growth (%)
|
-4.63 | -5.27 | 15.99 | -24.30 | 107.87 |
|
Net Profit Growth (%)
|
44.51 | -9.02 | -42.46 | -22.42 | 83.86 |
|
EPS Growth (%)
|
52.91 | -7.37 | -85.70 | -22.98 | 92.33 |
|
Book Value Growth (%)
|
5.02 | 8.50 | 2.72 | 14.81 | 0.78 |
Valuation Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Price / Earnings
|
6.79 | 21.49 | 63.69 | 22.66 | 20.66 |
|
Price / Book Value
|
0.32 | 5.75 | 2.47 | 3.94 | 5.77 |
|
Dividend Yield (%)
|
0.00 | 2.68 | 0.26 | 2.00 | 0.00 |
|
EV/EBITDA
|
7.83 | 15.63 | 29.85 | 14.39 | 16.01 |
|
Market Cap (₹ Cr)
|
15.67 | 17,158.99 | 13,549.79 | 7,237.65 | 4,532.48 |
Solvency Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.01 | 0.00 | 0.52 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.74 | 0.04 | 0.03 | -- | -- |
|
Current Ratio
|
1.47 | 2.31 | 1.88 | 2.68 | 4.56 |
|
Quick Ratio
|
0.47 | 1.83 | 0.83 | 2.06 | 4.22 |
|
Interest Coverage
|
1.64 | 60.93 | 3.03 | 81.13 | 211.80 |
Operating Efficiency Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
12.27 | 8.77 | 8.46 | 8.65 | 7.35 |
|
Asset Turnover
|
2.33 | 1.06 | 0.54 | 1.39 | 1.37 |
|
Receivable days
|
48.16 | 38.37 | 32.76 | 25.54 | 23.11 |
|
Inventory Days
|
102.34 | 34.17 | 55.91 | 32.35 | 18.94 |
|
Payable days
|
65.21 | 146.36 | 103.68 | 70.92 | 36.67 |
|
Cash Conversion Cycle
|
85.29 | -73.82 | -15.02 | -13.03 | 5.38 |